Lifecore Biomedical Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +280.0% | +252.6% | +5.7% | +491.9% | -8.9% | -4.0% | +4.9% | +6.8% | +13.0% | -9.2% | +13.3% | -1.1% | +1.0% | +16.2% | +14.8% | +39.1% | +7.9% | +13.1% | +0.3% | -1.6% | -1.5% | +6.4% | -71.3% | -37.0% | +84.2% | -40.1% | +15.3% | +0.5% | +0.5% | |
| – | +920.0% | +256.9% | +6.0% | +781.5% | -4.0% | -7.0% | +6.9% | +6.8% | +10.8% | -7.2% | +12.5% | +0.7% | +1.4% | +12.5% | +15.4% | +42.8% | +9.3% | +14.4% | -0.8% | -4.5% | -0.7% | +6.9% | -74.7% | -48.7% | +118.6% | -46.7% | +19.7% | +2.5% | +0.3% | |
| – | +120.0% | +247.7% | +5.2% | +144.9% | -30.0% | +13.6% | -4.9% | +7.3% | +25.2% | -19.1% | +18.0% | -10.3% | -1.5% | +38.3% | +11.7% | +20.4% | -0.3% | +4.5% | +8.5% | +17.2% | -5.8% | +3.4% | -51.4% | -1.1% | +29.4% | -22.4% | +7.1% | -3.7% | +0.8% | |
| – | +100.0% | -25.0% | +1.8% | -19.0% | -30.4% | +12.0% | +1.9% | -31.9% | +19.6% | +1.1% | +5.8% | +12.7% | +19.0% | +112.7% | +3.8% | -3.4% | -22.5% | -3.0% | +3.4% | +31.1% | +35.1% | -10.4% | -33.9% | -11.8% | +17.3% | 0.0% | +9.4% | -3.7% | +3.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +18.8% | -10.2% | +24.2% | +14.9% | -9.5% | -29.3% | -8.0% | +1.4% | +2.4% | – | |
| – | +76.3% | +38.8% | +3.2% | +106.5% | -23.7% | -0.5% | -14.4% | +0.9% | +19.5% | -93.5% | +1,040.6% | -5.9% | +1.7% | +53.6% | +6.7% | +4.8% | +11.8% | +10.8% | +20.9% | +19.3% | -4.3% | +16.6% | -13.6% | -26.8% | +13.0% | -5.8% | -0.3% | +13.5% | -27.2% | |
| – | – | – | – | – | – | – | +222.3% | +48.4% | +50.0% | +236.5% | -50.0% | -17.0% | -7.1% | -31.4% | +81.5% | +70.6% | -18.8% | -8.6% | -207.2% | – | -23.6% | -167.6% | – | – | – | – | – | – | – | |
| – | +13.3% | -23.5% | -69.2% | +970.5% | -48.4% | – | – | -86.2% | +500.0% | +99,679.2% | -92.8% | -99.5% | +1,000.0% | +831.8% | +13.3% | +116.1% | -17.8% | +10.8% | +8.6% | -8.1% | +6.8% | +168.2% | -11.2% | +92.3% | +94.3% | -10.4% | +16.3% | +20.7% | -89.9% | |
| – | – | – | – | – | – | – | +1,931.8% | +47.2% | +49.7% | +251.7% | -46.6% | -21.0% | -34.6% | -3.3% | +140.3% | +59.1% | -7.2% | -28.3% | -187.8% | – | +9.2% | -77.8% | -941.9% | – | – | – | – | -506.5% | – | |
| – | – | – | -50.0% | -142.0% | – | -83.0% | -59.0% | -45.0% | -36.0% | +520.2% | +36.6% | +67.3% | -24.0% | -1.9% | +71.8% | +31.6% | +12.0% | -26.8% | -195.6% | – | -316.0% | – | -678.0% | – | – | – | – | -76.5% | +1,243.5% | |
| – | – | – | – | – | – | – | – | +86.3% | +60.1% | +237.4% | -53.6% | -42.9% | -48.5% | -1.6% | +223.9% | +77.9% | -15.2% | -29.3% | -185.9% | – | +134.5% | -91.5% | -1,899.8% | – | – | – | – | -422.3% | – | |
| – | – | – | – | – | -35.1% | +71.0% | +63.1% | +22.2% | +28.9% | +175.0% | -45.3% | -7.3% | -28.2% | +19.0% | +85.3% | +54.0% | -6.9% | -21.5% | -125.7% | – | -6.3% | -6.1% | -130.5% | – | – | – | +177.2% | -124.8% | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.